首页> 外国专利> Method for Predicting if a patient is not responding to treatment with an agent specific Binding to a polypeptide of EGFR, which includes determining the presence or absence of a mutationK-ras and b-raf in a patient's tumor.

Method for Predicting if a patient is not responding to treatment with an agent specific Binding to a polypeptide of EGFR, which includes determining the presence or absence of a mutationK-ras and b-raf in a patient's tumor.

机译:预测患者是否对与EGFR多肽特异结合的试剂无反应的方法,该方法包括确定患者肿瘤中是否存在突变K-ras和b-raf。

摘要

The present application relates to K-ras mutations, to polynucleotides encoding mutant K-ras polypeptides, and to methods of identifying K-ras mutations. The present application also relates to B-raf mutations, to polynucleotides encoding mutant B-raf polypeptides, to vectors containing those polynucleotides, and to methods of identifying B-raf mutations. The present application also relates to methods of diagnosing cancer; and methods and kits for predicting the usefulness of anti-EGFr specific binding agents in the treatment of tumors.
机译:本申请涉及K-ras突变,编码突变K-ras多肽的多核苷酸以及鉴定K-ras突变的方法。本申请还涉及B-raf突变,编码突变的B-raf多肽的多核苷酸,包含这些多核苷酸的载体以及鉴定B-raf突变的方法。本申请还涉及诊断癌症的方法。以及预测抗EGFr特异性结合剂在肿瘤治疗中的有用性的方法和试剂盒。

著录项

  • 公开/公告号CL2008000716A1

    专利类型

  • 公开/公告日2008-09-22

    原文格式PDF

  • 申请/专利权人 AMGEN INC.;

    申请/专利号CL20080000716

  • 发明设计人 SIENA SALVATORE;BARDELLI ALBERTO.;

    申请日2008-03-11

  • 分类号C12Q1/00;C12Q1/68;

  • 国家 CL

  • 入库时间 2022-08-21 20:08:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号